Dive Into Dollar Tr...
Consumer Goods: Consumer Non-Durables
Rogers Corporation (ROG: NYSE)
$47.57 0.58 | 1.23%
05/17/13 - 04:05 PM ET
Portfolios with ROG
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProWestport Asset Management
- Useredlwhite Portfolio 1
- UserConfer Calls May/June 08 Ny...
- UserUCT
- UserPORT43GUYS
- Userbilawing Portfolio 1
- UserCB_discount
- UserOptions101
- UserNewTech
Latest ROG Headlines from TheStreet
- Rogers Is Now Oversold (ROG) 04.18.13 | 12:04 pm
- 5 Tech Stocks to Buy for 2013: SAP AG 12.07.12 | 02:12 pm
- Rogers Corporation Stock Upgraded (ROG) 08.02.12 | 05:08 am
- NYSE Stocks Posting Largest Percentage Increases 08.01.12 | 06:08 pm
- NYSE Stocks Posting Largest Percentage Increases 08.01.12 | 01:08 pm
- Rogers Corporation Stock Downgraded (ROG) 07.27.12 | 05:07 am
- Company Earnings Are About to Get a Lot Uglier in 2012 01.05.12 | 12:01 pm
- Rogers Reaches New 52-Week High (ROG) 08.02.11 | 10:08 am
- Rogers Reaches New 52-Week High (ROG) 07.22.11 | 02:07 pm
- Rogers Stock Hits New 52-Week High (ROG) 07.07.11 | 10:07 am
Press Releases for ROG
- Tucson Symposium Attracts Over 450 Global Scientists Focused On Personalized Healthcare - PR Newswire 03.08.13 | 01:03 pm
- Ventana And Biocare Medical Sign P63 License Agreement To Aid In The Differential Diagnosis Of Benign And Malignant Prostate Lesions - PR Newswire 02.26.13 | 01:02 pm
- Phase III Results Showed Omalizumab Significantly Reduced Disease Severity In Patients With A Chronic Form Of Hives Who Failed Standard Therapy - Business Wire 02.24.13 | 02:02 pm
- FDA Approves Genentech’s Kadcyla (Ado-Trastuzumab Emtansine), The First Antibody-Drug Conjugate For Treating HER2-Positive Metastatic Breast Cancer - Business Wire 02.22.13 | 09:02 am
- Rogers Corporation Reports 2012 Fourth Quarter And Year-End Results - Business Wire 02.19.13 | 04:02 pm
- Rogers Corporation Invites You To Join Its 2012 Fourth Quarter And Year-End Earnings Conference Call - Business Wire 02.12.13 | 11:02 am
- Obinutuzumab (GA101) Significantly Improved Progression-Free Survival In People With Chronic Lymphocytic Leukemia (CLL) - Business Wire 01.31.13 | 01:01 am
- Afraxis Grants Exclusive Global License To Genentech - PR Newswire 01.29.13 | 08:01 am
- Rogers Corporation Updates Guidance For The Fourth Quarter - Business Wire 01.29.13 | 07:01 am
- FDA Approves New Use Of Avastin Plus Chemotherapy For People With Metastatic Colorectal Cancer - Business Wire 01.23.13 | 05:01 pm
Partner Headlines for ROG
- Westlake Chemical Corp (WLK): Today's Most Compelling Buy - NASDAQ 03.06.13 | 05:03 pm
- Rogers Corporation - Momentum - Zacks 12.31.12 | 06:12 am
- Weekly CEO Buys Highlight: JPM, ROG, PBY, ANGO, MCHX - GuruFocus 07.21.12 | 08:07 pm
- President and CEO of Rogers Corp. Bought 3,299 Shares - GuruFocus 07.19.12 | 12:07 pm
- AMSC Posts Lower Loss - Analyst Blog - Zacks 06.07.12 | 09:06 am
- UPDATE 1-U.S. VA to halt Avastin use for eye disease-report - Reuters 09.21.11 | 02:09 pm
- Hoechner to Receive Equity Inducement Awards - Benzinga 09.21.11 | 01:09 pm
- Hoechner Named President and Chief Executive Officer of Rogers Corporation - Benzinga 09.21.11 | 01:09 pm
- Roche stops deliveries to some Greek hospitals-WSJ - Reuters 09.16.11 | 08:09 pm
- Moves from American Superconductor - Analyst Blog - Zacks 08.12.11 | 05:08 pm
